Pharming Other Non Cash Items from 2010 to 2025

PHAR Stock  USD 8.68  0.14  1.64%   
Pharming Group Other Non Cash Items yearly trend continues to be relatively stable with very little volatility. Other Non Cash Items is likely to grow to about -11.5 M this year. During the period from 2010 to 2025, Pharming Group Other Non Cash Items destribution of quarterly values had r-value of (0.48) from its regression line and median of  177,659. View All Fundamentals
 
Other Non Cash Items  
First Reported
2009-03-31
Previous Quarter
6.5 M
Current Value
-4.8 M
Quarterly Volatility
8.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 6.4 M or Selling And Marketing Expenses of 7.4 M, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 3.92. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
  
Check out the analysis of Pharming Group Correlation against competitors.

Latest Pharming Group's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Pharming Group NV over the last few years. It is Pharming Group's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Slightly volatile
   Other Non Cash Items   
       Timeline  

Pharming Other Non Cash Items Regression Statistics

Arithmetic Mean409,982
Coefficient Of Variation3,013
Mean Deviation8,850,738
Median177,659
Standard Deviation12,354,177
Sample Variance152.6T
Range46.8M
R-Value(0.48)
Mean Square Error125.3T
R-Squared0.23
Significance0.06
Slope(1,254,676)
Total Sum of Squares2289.4T

Pharming Other Non Cash Items History

2025-11.5 M
2024-12.2 M
2023-13.5 M
2022-11.3 M
2021-7.8 M
202033.3 M
2019-3.1 M

About Pharming Group Financial Statements

Pharming Group shareholders use historical fundamental indicators, such as Other Non Cash Items, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. The changes in Pharming Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharming Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Non Cash Items-12.2 M-11.5 M

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.